Synthesis of Verubecestat, a BACE1 Inhibitor for the Treatment of Alzheimer's Disease

被引：34

作者：

Thaisrivongs, David K. ^{[1
]}

Miller, Steven P. ^{[1
]}

Molinaro, Carmela ^{[1
]}

Chen, Qinghao ^{[1
]}

Song, Zhiguo J. ^{[1
]}

Tan, Lushi ^{[1
]}

Chen, Lu ^{[3
]}

Chen, Wenyong ^{[1
]}

Lekhal, Azzeddine ^{[2
]}

Pulicare, Sarah K. ^{[2
]}

Xu, Yanke ^{[2
]}

机构：

[1] Merck Res Labs, Proc Chem, POB 2000, Rahway, NJ 07065 USA

[2] Merck Res Labs, Chem Engn Res & Dev, Proc Res & Dev, POB 2000, Rahway, NJ 07065 USA

[3] WuXi AppTec Shanghai Pharmaceut Co Ltd, 288 Fute Zhong Rd, Shanghai 200131, Peoples R China

来源：

ORGANIC LETTERS | 2016年 / 18卷 / 22期

关键词：

EFFICIENT COPPER CATALYST; ARYL HALIDES; AMIDATION; AMINES;

D O I：

10.1021/acs.orglett.6b01793

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

Verubecestat is an inhibitor of beta-secretase being evaluated for the treatment of Alzheimer's disease. The first generation route relies on an amide coupling with a functionalized aniline, the preparation of which introduces synthetic inefficiencies. The second-generation route replaces this with a copper-catalyzed C-N coupling, allowing for more direct access to the target. Other features of the new route include a diastereoselective Mannich-type addition into an Ellman sulfinyl ketimine and a late-stage guanidinylation.

引用

页码：5780 / 5783

页数：4

共 13 条

[1] Asymmetric synthesis of α,α-dibranched amines by the trimethylaluminum-mediated 1,2-addition of organolithiums to tert-butanesulfinyl ketimines
Cogan, DA
Ellman, JA
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (01) : 268 - 269
[2] Duthey B, 2013, BACKGROUND PAPER 6 1
[3] A highly active catalyst for Pd-catalyzed amination reactions: Cross-coupling reactions using aryl mesylates and the highly selective monoarylation of primary amines using aryl chlorides
Fors, Brett P.
Watson, Donald A.
Biscoe, Mark R.
Buchwald, Stephen L.
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (41) : 13552 - +
[4] The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer's disease patients
Kennedy, Matthew E.
Stamford, Andrew W.
Chen, Xia
Cox, Kathleen
Cumming, Jared N.
Dockendorf, Marissa F.
Egan, Michael
Ereshefsky, Larry
Hodgson, Robert A.
Hyde, Lynn A.
Jhee, Stanford
Kleijn, Huub J.
Kuvelkar, Reshma
Li, Wei
Mattson, Britta A.
Mei, Hong
Palcza, John
Scott, Jack D.
Tanen, Michael
Troyer, Matthew D.
Tseng, Jack L.
Stone, Julie A.
Parker, Eric M.
Forman, Mark S.
[J]. SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (363)
[5] A general and efficient copper catalyst for the amidation of aryl halides and the N-arylation of nitrogen heterocycles
Klapars, A
Antilla, JC
Huang, XH
Buchwald, SL
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (31) : 7727 - 7729
[6] A general and efficient copper catalyst for the amidation of aryl halides
Klapars, A
Huang, XH
Buchwald, SL
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (25) : 7421 - 7428
[7] Li G., 2011, [No title captured], Patent No. [2011/044181 Al, 2011044181, WO2011044181A1]
[8] A General Method for Imine Formation Using B(OCH2CF3)(3)
Reeves, Jonathan T.
Visco, Michael D.
Marsini, Maurice A.
Grinberg, Nelu
Busacca, Carl A.
Mattson, Anita E.
Senanayake, Chris H.
[J]. ORGANIC LETTERS, 2015, 17 (10) : 2442 - 2445
[9] Direct Titanium-Mediated Conversion of Ketones into Enamides with Ammonia and Acetic Anhydride
Reeves, Jonathan T.
Tan, Zhulin
Han, Zhengxu S.
Li, Guisheng
Zhang, Yongda
Xu, Yibo
Reeves, Diana C.
Gonnella, Nina C.
Ma, Shengli
Lee, Heewon
Lu, Bruce Z.
Senanayake, Chris H.
[J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (06) : 1400 - 1404
[10] Synthesis and Applications of tert-Butanesulfinamide
Robak, MaryAnn T.
Herbage, Melissa A.
Ellman, Jonathan A.
[J]. CHEMICAL REVIEWS, 2010, 110 (06) : 3600 - 3740

← 1 2 →